Would you ever consider pelvic exenteration followed by SBRT for a patient with recurrent cervical cancer (s/p chemoRT) who has disease only in the central pelvis and in a single hilar lymph node?

Certainly the distant disease makes the risk of recurrence after exenteration very high. On the other hand, the patient is 2 years out from initial treatment and disease seems to be slow-growing.

Answer from: at Academic Institution

I would consider it.

Answer from: at Academic Institution

I think this is a tough question. The short of it would be that I would be very cautious with exent candidacy with extra-pelvic disease. The surgical morbidity and limited ability to get additional therapy are a reality. Scenarios where I might consider would be a long duration of time off therapy. ...

Comments

at Washington University School of Medicine
I agree. If the tumor highly expressed PD-L1, I mi...

Please select the option that best describes you:

Would you ever consider pelvic exenteration followed by SBRT for a patient with recurrent cervical cancer (s/p chemoRT) who has disease only in the central pelvis and in a single hilar lymph node?

Related Questions